Pfizer Group B strep vaccine for infants returns encouraging mid-stage trial results
Pfizer is among several drugmakers racing to develop the world's first shot targeting Group B strep disease, which kills thousands of infants each year.
Source link
/cloudfront-us-east-2.images.arcpublishing.com/reuters/3XNZ2CRY3JKTXNCMXKUXDIDFGU.jpg "Six more U.S. states find Omicron cases, Delta still top U.S. coronavirus threat")
